What labs should be ordered to assess hyponatremia in a patient on an SNRI (serotonin‑norepinephrine reuptake inhibitor) such as venlafaxine or duloxetine?

Laboratory Workup for SNRI-Associated Hyponatremia

Order serum sodium, serum osmolality, urine sodium, urine osmolality, and serum uric acid to evaluate hyponatremia in patients on SNRIs, as these labs distinguish SIADH (the most common mechanism) from other causes and guide management.

Initial Laboratory Panel

When hyponatremia is suspected in a patient on an SNRI (venlafaxine, duloxetine, desvenlafaxine), obtain the following tests:

Essential Labs

• Serum sodium - confirms hyponatremia (typically <135 mmol/L, often <130 mmol/L)
• Serum osmolality - distinguishes true hypotonic hyponatremia from pseudohyponatremia 1
• Urine sodium - values >30 mmol/L suggest SIADH rather than volume depletion 1
• Urine osmolality - inappropriately concentrated urine (>100 mOsm/kg) despite low serum osmolality indicates SIADH 1
• Serum uric acid - levels <4 mg/dL have 73-100% positive predictive value for SIADH 1

Additional Recommended Labs

• Serum potassium - frequently affected alongside sodium with SNRI use 2
• Serum magnesium - may be altered concurrently 2
• Serum creatinine - assess renal function and rule out renal causes 2
• Thyroid function (TSH) - exclude hypothyroidism as alternative cause 1

Timing of Laboratory Monitoring

Check serum sodium 3-5 days after initiating SNRI therapy in patients >65 years, as hyponatremia typically develops within the first week of treatment 3. The FDA drug labels for both duloxetine and venlafaxine acknowledge hyponatremia as a known adverse effect, often presenting as SIADH 4, 5.

High-Risk Populations Requiring Earlier/More Frequent Monitoring

• Age ≥65 years - particularly women ≥80 years (6.5% incidence) 6
• Concurrent diuretic use - especially thiazides 4, 5
• Volume depletion from any cause 4, 5
• Low body mass index 7
• History of prior hyponatremia 2, 7

Diagnostic Algorithm Based on Lab Results

If Serum Osmolality is Normal or High (>280 mOsm/L)

Consider pseudohyponatremia from:

• Hyperglycemia
• Hypertriglyceridemia
• Laboratory error 1

If Serum Osmolality is Low (<280 mOsm/L) - True Hyponatremia

Assess volume status clinically (though physical exam alone has only 41% sensitivity) 1:

Euvolemic with Urine Na >30 mmol/L and Urine Osmolality >100 mOsm/kg

Diagnosis: SIADH - the most common mechanism with SNRIs 4, 5, 3

• Serum uric acid <4 mg/dL supports this diagnosis 1
• ADH levels are NOT diagnostically useful 1

Hypovolemic with Urine Na <30 mmol/L

Consider volume depletion from other causes requiring saline responsiveness testing 1

Critical Pitfalls to Avoid

1. Don't rely on physical exam alone for volume status assessment - sensitivity is only 41% 1

2. Don't order ADH levels - they have limited diagnostic value and SIADH can occur with undetectable ADH 1

3. Don't assume normal baseline sodium rules out SIADH - one case report documented progression from sodium 135 mmol/L to 119 mmol/L within 3 days of duloxetine initiation 8

4. Don't delay checking sodium in elderly patients - the highest risk period is the first 2 weeks (aOR 10.06) with 3-4% of patients ≥65 years developing profound hyponatremia 6

5. Monitor for concurrent electrolyte abnormalities - potassium, magnesium, and creatinine may also be affected 2

Severity Classification

• Mild: 130-135 mmol/L
• Moderate: 125-129 mmol/L
• Severe/Profound: <125 mmol/L (requires urgent intervention) 6

Cases with serum sodium <110 mmol/L have been reported with both duloxetine and venlafaxine 4, 5.